Clinic of Neonatology, Lausanne University Hospital, Lausanne, Switzerland.
Division of Neonatology, Stead family Children's Hospital, Iowa City, Iowa, USA.
J Neonatal Perinatal Med. 2021;14(4):493-502. doi: 10.3233/NPM-200518.
To determine the association between plasma hemoglobin (HB) at three time-points (birth, postnatal days 0-3 and 0-10) and spontaneous closure of the ductus arteriosus (sDAC).
A retrospective case-control study of preterm infants born (2013-2016) between 24 and 29 weeks of gestational age (GA) was conducted in a level three perinatal center in Switzerland. We collected hemoglobin at birth, between days 0-3 and 0-10 in two distinct groups: (i) patients treated for a PDA and (ii) patients with spontaneous closure of the ductus arteriosus (sDAC). Antenatal and postnatal demographic data and neonatal morbidity were collected. Bivariate analysis was performed and a stepwise logistic regression was done to investigate factors associated with sDAC.
We reviewed the medical chart of 184 premature infants of whom 146 (79.3%) satisfied eligibility criteria. Of these, 74 (51%) were classified as sDAC. Patients with sDAC were older (GA: 28 vs 27, p < 0.001), more stable (clinical risk index for babies score (CRIB score): 2 vs 5, p < 0.001) and had better clinical outcomes than patients who received treatment for a PDA. Infants in the sDAC group had a higher level of hemoglobin during the first ten postnatal days. Multiple logistic regression analysis revealed that lower HB level (day 0-10) were associated with failure of sDAC (p < 0.05).
This is one of the first studies to highlight a potential association between hemoglobin during the transitional period and sDAC. The biological nature of this observation requires prospective clarification.
确定三个时间点(出生时、生后 0-3 天和 0-10 天)的血浆血红蛋白(HB)与动脉导管未闭(PDA)自然闭合之间的关系。
这是一项在瑞士三级围产中心进行的早产儿回顾性病例对照研究,研究对象为 24 至 29 孕周出生的(2013-2016 年)婴儿。我们在两组中收集出生时、生后 0-3 天和 0-10 天的血红蛋白:(i)接受 PDA 治疗的患者和(ii)动脉导管自然闭合(sDAC)的患者。收集了产前和产后的人口统计学数据和新生儿发病率。进行了双变量分析,并进行了逐步逻辑回归以调查与 sDAC 相关的因素。
我们回顾了 184 名早产儿的病历,其中 146 名(79.3%)符合入选标准。其中,74 名(51%)被归类为 sDAC。与接受 PDA 治疗的患者相比,sDAC 患者的胎龄更大(GA:28 与 27,p<0.001),更为稳定(婴儿临床风险指数评分(CRIB 评分):2 与 5,p<0.001),临床结局更好。sDAC 组的婴儿在出生后 10 天内的血红蛋白水平更高。多变量逻辑回归分析显示,第 0-10 天的 HB 水平较低与 sDAC 失败相关(p<0.05)。
这是首批强调过渡期间血红蛋白与 sDAC 之间潜在关联的研究之一。这种观察的生物学性质需要前瞻性澄清。